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A population-based case–control study (Zahm et al, 1989)
conducted in Kansas, USA and based on 133 cases showed that the
risk of soft-tissue sarcoma (STS) increased with adult body
weight, the odds ratio (OR) being 2.0 for people weighing more
than 200 pounds. To provide further information on this issue, we
analysed data from a large case–control study conducted in Italy.
SUBJECTS AND METHODS
Data were derived from a case–control study of STS, conducted
between 1983 and 1998 in the greater Milan area and the province
of Pordenone, northern Italy (Serraino et al, 1991; Tavani et al,
1997).
Cases were 217 patients (113 men, median age 52 years, range
21–79; and 104 women, median age 54 years, range 16–79)
with histologically confirmed incident (i.e. diagnosed within the
year preceding the interview) STS (International Classification
of Diseases IX Edition ICD-171) admitted to the cancer institutes
and major teaching and general hospitals of the areas under
surveillance.
Controls were 1297 patients (792 men, median age 55 years,
range 17–79; and 505 women, median age 57 years, range 17–79)
admitted to the same network of hospitals for acute, non-
neoplastic and non-immune-related conditions. Of the comparison
group, 15% were admitted for traumas, 27% for other orthopaedic
disorders (such as low back pain and disc diseases), 29% for acute
surgical conditions (such as acute appendicitis or strangulated
hernia), and 28% for other miscellaneous illnesses (such as ear,
nose and throat, eye, dental or skin disorders). On average, fewer
than 4% of the eligible cases and controls refused the interview.
Trained interviewers used a structured questionnaire to collect
data on socio-demographic characteristics, anthropometric
measures (self-reported weight and height), personal and family
history of selected medical conditions, a few selected occupational
and environmental exposures, smoking status and consumption of
alcohol, coffee and selected dietary items.
Data analysis
Body mass index (BMI) was computed according to Quetelet’s
index (weight height–2, kg m–2), which is essentially an indicator of
weight unrelated to height (Benn, 1971). Odds ratios (OR) with
their corresponding 95% confidence intervals (CI) were derived
using unconditional multiple logistic regression analysis, fitted by
the method of maximum likelihood (Breslow and Day, 1980). The
regression models included terms for study centre, year of recruit-
ment, age (8 levels plus a continuous term) and education.
RESULTS
Table 1 gives the distribution of STS cases and controls by sex
according to age and BMI, and the OR of STS according to BMI.
The risk of STS rose with BMI, and the OR was 3.28 in subjects
with a BMI > 30 compared to those with BMI ≤ 20. The OR was
3.49 for men and 3.26 for women. The risk estimates did not
change after further adjustment for employment in agriculture and
radiation therapy: the OR became 3.41 and 3.53 respectively for
men and women with BMI > 30 compared to those with BMI ≤ 20.
A separate analysis for broad categories of anatomical sites of
STS showed no differences in the strength of association by site:
the OR for BMI > 30 compared to ≤ 20 for men and women
combined was 3.02 (95% CI 1.21–7.52) for STS in the upper or
lower limbs (ICD 171.2 and 171.3), 3.75 (95% CI 0.94–14.96) for
STS in the abdomen or pelvis (ICD 171.5 and 171.6) and 2.88
(95% CI 0.66–12.58) for those arising in other or unspecified sites.
Height was not associated with risk of STS; the OR for the
highest quartile compared to the lowest one was 1.14 (95% CI
0.59–2.22) in men and 0.50 (95% CI 0.25–0.99) in women.
DISCUSSION
The results of this study suggest a direct association between risk
of STS and BMI in men and women and no relation with height, in
agreement with the findings of Zahm et al (1989).
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Overweight and obesity are major public health issues and are
associated with several chronic diseases and shorter life
expectancy (Manson et al, 1987), probably through multiple
biological mechanisms. Obese subjects were at elevated risk of
leukaemias and lymphomas in the American Cancer Society
cohort study conducted between 1959 and 1972 (Lew and
Garfinkel, 1979). It is biologically plausible that overweight and
obese people may be at higher risk of STS as, besides radiation,
selected chemicals and some drugs and infectious agents (Zahm
et al, 1996; Zahm and Fraumeni, 1997), herbicides and pesticides,
particularly those containing 2,3,7,8-tetrachlorodibenzo-p-dioxin,
chlorophenols and dibenzofurans, have been associated to STS
risk (Hoar et al, 1986; Kang et al, 1987; Woods et al, 1987; Reif
et al, 1989; Saracci et al, 1991; Bertazzi et al, 1993; Kogevinas et
al, 1997; Hoppin et al, 1998), and most of these chemicals accu-
mulate in human adipose tissue (Patterson et al, 1996; Kang et al,
1991; Orban et al, 1994). Very lean subjects may be selectively at
low risk because of inherent characteristics of their adipose tissue,
and of its specific role in STS pathogenesis. Moreover, immuno-
logical and hormonal imbalances in obese subjects have been
reported, including changes in leptin (Friedman, 1997) and insulin
growth factors, that regulate metabolism and play an important
role in proliferation and apoptosis of several cell types
(Daughaday, 1990; Tritos and Mantzoros, 1998), and that have
been related to the risk of several neoplasms (Mantzoros et al,
1997; Petridou et al, 1999).
A possible source of bias in this study is the misclassification of
body mass (Millar, 1986; Nieto-Garcia et al, 1990), as self-
reported measures tend to overestimate height and underestimate
weight (Palta et al, 1982; Stewart, 1982; Millar, 1986; Nieto-
Garcia et al, 1990). However, such information bias is likely to be
similar for cases and controls, and cannot explain the strong asso-
ciation observed. Hospital controls may differ from the general
population in several respects (Breslow and Day, 1980). However,
overweight and obesity are related to an increased prevalence of
several chronic diseases (Negri et al, 1988; Pagano et al, 1997), so
the use of hospital controls should, if anything, underestimate the
true association (Breslow and Day, 1980).
A major difficulty in this and other epidemiological studies on
STS is the relatively low incidence and wide heterogeneity of this
neoplasm, as aetiological differences by subsite and cell type have
been suggested (Zahm et al, 1996; Zahm and Fraumeni, 1997).
The prevalence of overweight and obesity has been rising over
the last few years in Italy (Pagano et al, 1997) and other Western
countries (Galuska et al, 1996). This might partly explain the
increased trends in incidence and mortality from STS (La Vecchia
et al, 1992; Ross et al, 1993).
Thus, these data suggest that BMI is directly related to STS risk,
and offer another reason for public health interventions to reduce
overweight and obesity.
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